首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
GolimumabFulminant demyelinating disease: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2020年
/ 1809卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-020-79902-6
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:118 / 118
相关论文
共 50 条
[21]
FingolimodTumefactive demyelinating lesion: case report
Reactions Weekly,
2023,
1981
(1)
: 182
-
182
[22]
AlemtuzumabTumefactive demyelinating lesion: case report
Reactions Weekly,
2017,
1650
(1)
: 24
-
24
[23]
FingolimodTumefactive demyelinating lesions: case report
Reactions Weekly,
2017,
1681
(1)
: 155
-
155
[24]
NivolumabAcute demyelinating polyneuropathy: case report
Reactions Weekly,
2018,
1701
(1)
: 214
-
214
[25]
FingolimodTumefactive demyelinating lesions: case report
Reactions Weekly,
2019,
1734
(1)
: 230
-
230
[26]
TozinameranInflammatory demyelinating polyneuropathy: case report
Reactions Weekly,
2022,
1917
(1)
: 549
-
549
[27]
NivolumabAcute demyelinating polyneuropathy: case report
Reactions Weekly,
2018,
1687
(1)
: 169
-
169
[28]
AtezolizumabAcute demyelinating polyneuropathy: case report
Reactions Weekly,
2022,
1888
(1)
: 76
-
76
[29]
IsotretinoinCerebellar demyelinating lesion: case report
Reactions Weekly,
2008,
1194-1195
(1)
: 22
-
22
[30]
NatalizumabTumefactive demyelinating lesions: case report
Reactions Weekly,
2019,
1748
(1)
: 372
-
372
←
1
2
3
4
5
→